(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Novavax, First Citizens BancShares, and argenx SE.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Novavax (NVAX) 239.70 10.3% 2021-12-20 07:28:52
2 First Citizens BancShares (FCNCA) 834.70 8.97% 2021-12-20 04:11:08
3 argenx SE (ARGX) 336.08 8.32% 2021-12-20 04:36:47
4 Advanced Semiconductor Engineering (ASX) 7.80 6.85% 2021-12-20 04:38:20
5 Moderna (MRNA) 314.72 6.76% 2021-12-20 07:32:38
6 BeiGene (BGNE) 289.99 5.95% 2021-12-20 07:31:14
7 Biogen (BIIB) 245.00 3.19% 2021-12-20 07:24:44
8 Zoom (ZM) 206.00 3.13% 2021-12-20 07:32:50
9 Ball Corporation (BLL) 94.99 2.37% 2021-12-20 07:20:05
10 Roper Industries (ROP) 486.37 2.28% 2021-12-20 04:45:29

The three most active and biggest losers today are U.S. Gold Corp, West Pharmaceutical, and Marathon Oil.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 U.S. Gold Corp (USAU) 7.46 -7.44% 2021-12-20 06:48:35
2 West Pharmaceutical (WST) 424.54 -5.62% 2021-12-20 07:25:37
3 Marathon Oil (MRO) 14.32 -5.48% 2021-12-20 04:43:33
4 Plug Power (PLUG) 28.15 -5.38% 2021-12-20 07:29:08
5 Banco Bradesco (BBDO) 3.01 -5.35% 2021-12-20 04:38:44
6 Marathon (MARA) 32.15 -5.04% 2021-12-20 07:28:13
7 LendingTree (TREE) 115.00 -4.8% 2021-12-20 05:00:37
8 Occidental Petroleum (OXY) 26.71 -4.74% 2021-12-20 04:44:25
9 QuantumScape (QS) 22.66 -4.71% 2021-12-20 04:48:37
10 Uber (UBER) 37.83 -4.66% 2021-12-20 04:35:09

Most Active Premarket Winners today

1. Novavax (NVAX) – Premarket: 10.3%

NASDAQ Composite ended the session with Novavax jumping 11.49% to $217.32 on Monday, after five consecutive sessions in a row of gains. NASDAQ Composite slid 0.07% to $15,169.68, after five sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Novavax is 10683900, 100.92% above its average volume of 5317440.

Novavax’s last close was $217.32, 34.48% below its 52-week high of $331.68.

The company’s growth estimates for the present quarter is a negative 21.8% and positive 213.7% for the next.

Novavax’s Revenue

Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 1.2B for the twelve trailing months.

Volatility

Novavax’s last week, last month’s, and last quarter’s current intraday variation average was 9.35%, 0.86%, and 5.43%, respectively.

Novavax’s highest amplitude of average volatility was 9.35% (last week), 5.96% (last month), and 5.43% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be oversold (<=20).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $217.32 at 07:34 EST, way below its 52-week high of $331.68 and way higher than its 52-week low of $107.08.

Novavax’s Moving Average

Novavax’s worth is way higher than its 50-day moving average of $170.98 and way higher than its 200-day moving average of $193.54.

Previous days news about Novavax

  • Hagens berman, national trial attorneys, alerts Novavax (nvax) investors jan. 11th deadline in securities class action, encourages investors with losses to contact firm's attorneys. According to Benzinga on Saturday, 18 December, "Later that day, Novavax confirmed it was unlikely to seek EUA for NVX-CoV2373 until July at the earliest. ", "We’re focused on investors’ losses and proving Novavax lied about its EUA timeline for NVX-CoV2373," said Reed Kathrein, the Hagens Berman partner leading the investigation."
  • Here's how much $100 invested in Novavax 10 years ago would be worth today. According to Benzinga on Saturday, 18 December, "Buying $100 In NVAX: 10 years ago, an investor could have purchased 3.97 shares of Novavax at the time with $100. "

More news about Novavax.

2. First Citizens BancShares (FCNCA) – Premarket: 8.97%

NASDAQ Composite ended the session with First Citizens BancShares dropping 2.48% to $766.02 on Monday, after five consecutive sessions in a row of losses. NASDAQ Composite dropped 0.07% to $15,169.68, after five sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for First Citizens BancShares is 98807, 81.77% above its average volume of 54358.

First Citizens BancShares’s last close was $766.02, 16.32% under its 52-week high of $915.40.

First Citizens BancShares’s Revenue

Year-on-year quarterly revenue growth grew by 0.2%, now sitting on 1.94B for the twelve trailing months.

Volatility

First Citizens BancShares’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.72%, a negative 0.85%, and a positive 1.70%, respectively.

First Citizens BancShares’s highest amplitude of average volatility was 2.72% (last week), 2.19% (last month), and 1.70% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

First Citizens BancShares’s stock is considered to be overbought (>=80).

First Citizens BancShares’s Stock Yearly Top and Bottom Value

First Citizens BancShares’s stock is valued at $766.02 at 07:34 EST, way below its 52-week high of $915.40 and way higher than its 52-week low of $558.44.

First Citizens BancShares’s Moving Average

First Citizens BancShares’s worth is under its 50-day moving average of $838.44 and below its 200-day moving average of $840.19.

More news about First Citizens BancShares.

3. argenx SE (ARGX) – Premarket: 8.32%

NASDAQ Composite ended the session with argenx SE jumping 4.42% to $310.26 on Monday while NASDAQ Composite dropped 0.07% to $15,169.68.

Volume

Today’s last reported volume for argenx SE is 140883, 26.44% below its average volume of 191542.

argenx SE’s last close was $310.26, 18.81% under its 52-week high of $382.15.

argenx SE’s Sales

argenx SE’s sales growth is 20.4% for the current quarter and a decline by 32.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 12.1% and a negative 10.2%, respectively.

argenx SE’s Revenue

Year-on-year quarterly revenue growth grew by 3921.2%, now sitting on 517.83M for the twelve trailing months.

Volatility

argenx SE’s last week, last month’s, and last quarter’s current intraday variation average was 0.88%, 2.02%, and 2.31%, respectively.

argenx SE’s highest amplitude of average volatility was 1.31% (last week), 2.82% (last month), and 2.31% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

argenx SE’s stock is considered to be oversold (<=20).

argenx SE’s Stock Yearly Top and Bottom Value

argenx SE’s stock is valued at $310.26 at 07:34 EST, way under its 52-week high of $382.15 and way higher than its 52-week low of $248.21.

argenx SE’s Moving Average

argenx SE’s worth is higher than its 50-day moving average of $301.51 and higher than its 200-day moving average of $303.05.

More news about argenx SE.

4. Advanced Semiconductor Engineering (ASX) – Premarket: 6.85%

NYSE Composite ended the session with Advanced Semiconductor Engineering rising 0.83% to $7.30 on Monday while NYSE Composite fell 1.07% to $16,668.64.

Volume

Today’s last reported volume for Advanced Semiconductor Engineering is 4253600, 3.42% below its average volume of 4404570.

Advanced Semiconductor Engineering’s last close was $7.30, 24.12% under its 52-week high of $9.62.

Advanced Semiconductor Engineering’s Sales

Advanced Semiconductor Engineering’s sales growth is 28.8% for the present quarter and 11.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 100% and 31.2%, respectively.

Advanced Semiconductor Engineering’s Revenue

Year-on-year quarterly revenue growth grew by 18%, now sitting on 518.47B for the twelve trailing months.

Volatility

Advanced Semiconductor Engineering’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.85%, a negative 2.27%, and a positive 2.55%, respectively.

Advanced Semiconductor Engineering’s highest amplitude of average volatility was 2.09% (last week), 3.10% (last month), and 2.55% (last quarter), respectively.

Advanced Semiconductor Engineering’s Stock Yearly Top and Bottom Value

Advanced Semiconductor Engineering’s stock is valued at $7.30 at 07:34 EST, way under its 52-week high of $9.62 and way higher than its 52-week low of $4.87.

Advanced Semiconductor Engineering’s Moving Average

Advanced Semiconductor Engineering’s value is under its 50-day moving average of $7.32 and way under its 200-day moving average of $8.16.

More news about Advanced Semiconductor Engineering.

5. Moderna (MRNA) – Premarket: 6.76%

NASDAQ Composite ended the session with Moderna jumping 4.53% to $294.80 on Monday while NASDAQ Composite slid 0.07% to $15,169.68.

Volume

Today’s last reported volume for Moderna is 10627500, 17.06% below its average volume of 12813800.

Moderna’s last close was $294.80, 40.74% under its 52-week high of $497.49.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the present quarter and 1202.8% for the next. The company’s growth estimates for the present quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current intraday variation average was 7.83%, 1.56%, and 4.67%, respectively.

Moderna’s highest amplitude of average volatility was 7.83% (last week), 5.54% (last month), and 4.67% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be oversold (<=20).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $294.80 at 07:34 EST, way under its 52-week high of $497.49 and way higher than its 52-week low of $102.66.

Moderna’s Moving Average

Moderna’s worth is under its 50-day moving average of $298.96 and way above its 200-day moving average of $267.83.

Previous days news about Moderna

  • CDC recommends Pfizer, Moderna Covid-19 vaccines over j&j due to rare blood clots. According to Business Insider on Friday, 17 December, "U.S. Centers for Disease Control and Prevention or CDC recommends that people take the mRNA COVID-19 vaccines made by Pfizer and Moderna instead of Johnson & Johnson’s single-shot COVID-19 vaccine due to a rare blood clotting disorder."
  • Moderna shot had more heart risk than Pfizer’s in danish study. According to Bloomberg Quint on Friday, 17 December, "The risk of rare heart inflammation side effects was as much as four times higher in people who received Moderna Inc.’s Covid-19 shot than in those who got the vaccine from Pfizer Inc. and BioNTech SE, according to researchers in Denmark.", "About 4.2 people per 100,000 who got the Moderna vaccine developed myocarditis or myopericarditis within 28 days of vaccination, with the highest risk seen in those age 12 to 39 and after people received their second doses, according to the study, which was published in the BMJ."

More news about Moderna.

6. BeiGene (BGNE) – Premarket: 5.95%

NASDAQ Composite ended the session with BeiGene jumping 0.25% to $273.71 on Monday, following the last session’s upward trend. NASDAQ Composite fell 0.07% to $15,169.68, after five successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for BeiGene is 604876, 148.3% above its average volume of 243606.

BeiGene’s last close was $273.71, 35.83% below its 52-week high of $426.56.

News about BeiGene today

  • Beigene to receive up to $1 billion in oncology deal with novartis. According to today’s article on MarketWatch, "Beijing-based BeiGene will receive an upfront payment of $300 million up to $700 million more on exercise by Novartis of a time-based option prior to mid-2023. "

BeiGene’s Sales

BeiGene’s sales growth is 188.9% for the ongoing quarter and 161.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 19.3% and a negative 0.4%, respectively.

BeiGene’s Revenue

Year-on-year quarterly revenue growth grew by 1063.8%, now sitting on 862.69M for the twelve trailing months.

Volatility

BeiGene’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.68%, a negative 2.85%, and a positive 2.52%, respectively.

BeiGene’s highest amplitude of average volatility was 7.81% (last week), 3.53% (last month), and 2.52% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

BeiGene’s stock is considered to be oversold (<=20).

BeiGene’s Stock Yearly Top and Bottom Value

BeiGene’s stock is valued at $273.71 at 07:34 EST, way below its 52-week high of $426.56 and way higher than its 52-week low of $224.74.

BeiGene’s Moving Average

BeiGene’s worth is way below its 50-day moving average of $356.29 and way under its 200-day moving average of $336.12.

More news about BeiGene.

7. Biogen (BIIB) – Premarket: 3.19%

NASDAQ Composite ended the session with Biogen jumping 0.81% to $237.43 on Monday while NASDAQ Composite dropped 0.07% to $15,169.68.

Volume

Today’s last reported volume for Biogen is 2267430, 96.05% above its average volume of 1156530.

Biogen’s last close was $237.43, 49.33% under its 52-week high of $468.55.

The company’s growth estimates for the present quarter and the next is a negative 53.3% and a negative 25.1%, respectively.

Biogen’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 11.7B for the twelve trailing months.

Volatility

Biogen’s last week, last month’s, and last quarter’s current intraday variation average was 0.86%, 0.81%, and 1.52%, respectively.

Biogen’s highest amplitude of average volatility was 1.13% (last week), 1.89% (last month), and 1.52% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Biogen’s stock is considered to be oversold (<=20).

Biogen’s Stock Yearly Top and Bottom Value

Biogen’s stock is valued at $237.43 at 07:34 EST, way below its 52-week high of $468.55 and higher than its 52-week low of $221.72.

Biogen’s Moving Average

Biogen’s worth is below its 50-day moving average of $261.96 and way under its 200-day moving average of $297.53.

Previous days news about Biogen

  • Biogen alzheimer’s drug gets negative EU regulator opinion. According to Bloomberg Quint on Friday, 17 December, "A key panel of the European Union’s drugs regulator issued a negative opinion on Biogen Inc.’s controversial treatment for Alzheimer’s disease, dimming the hopes for marketing the drug in the region.", "Shares of Cambridge, Mass.-based Biogen fell 4.2% in early trading before U.S. markets opened. "

More news about Biogen.

8. Zoom (ZM) – Premarket: 3.13%

NASDAQ Composite ended the session with Zoom rising 9.51% to $199.74 on Monday, after two successive sessions in a row of gains. NASDAQ Composite slid 0.07% to $15,169.68, after five sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Zoom is 10361400, 137.49% above its average volume of 4362740.

Zoom’s last close was $199.74, 55.79% under its 52-week high of $451.77.

The company’s growth estimates for the ongoing quarter is 10.1% and a drop 13.9% for the next.

Zoom’s Revenue

Year-on-year quarterly revenue growth grew by 35.2%, now sitting on 3.91B for the twelve trailing months.

Volatility

Zoom’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.74%, a negative 0.42%, and a positive 2.54%, respectively.

Zoom’s highest amplitude of average volatility was 3.70% (last week), 3.36% (last month), and 2.54% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zoom’s stock is considered to be oversold (<=20).

Zoom’s Stock Yearly Top and Bottom Value

Zoom’s stock is valued at $199.74 at 07:34 EST, way below its 52-week high of $451.77 and way higher than its 52-week low of $175.27.

Zoom’s Moving Average

Zoom’s worth is way under its 50-day moving average of $246.95 and way below its 200-day moving average of $312.18.

More news about Zoom.

9. Ball Corporation (BLL) – Premarket: 2.37%

NYSE Composite ended the session with Ball Corporation jumping 0.49% to $92.79 on Monday while NYSE Composite slid 1.07% to $16,668.64.

Volume

Today’s last reported volume for Ball Corporation is 4041230, 130.33% above its average volume of 1754530.

Ball Corporation’s last close was $92.79, 5.4% under its 52-week high of $98.09.

Ball Corporation’s Sales

Ball Corporation’s sales growth is 17.4% for the present quarter and 13.7% for the next. The company’s growth estimates for the present quarter and the next is 12.4% and 22.2%, respectively.

Ball Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 12.78B for the twelve trailing months.

Volatility

Ball Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.94%, a negative 0.15%, and a positive 1.13%, respectively.

Ball Corporation’s highest amplitude of average volatility was 1.22% (last week), 1.00% (last month), and 1.13% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ball Corporation’s stock is considered to be oversold (<=20).

Ball Corporation’s Stock Yearly Top and Bottom Value

Ball Corporation’s stock is valued at $92.79 at 07:34 EST, under its 52-week high of $98.09 and way above its 52-week low of $77.95.

Ball Corporation’s Moving Average

Ball Corporation’s value is higher than its 50-day moving average of $92.41 and above its 200-day moving average of $88.47.

More news about Ball Corporation.

10. Roper Industries (ROP) – Premarket: 2.28%

NYSE Composite ended the session with Roper Industries sliding 2.35% to $475.52 on Monday while NYSE Composite fell 1.07% to $16,668.64.

Volume

Today’s last reported volume for Roper Industries is 704157, 92.31% above its average volume of 366141.

Roper Industries’s last close was $475.52, 5.84% below its 52-week high of $505.00.

Roper Industries’s Sales

Roper Industries’s sales growth is 18.8% for the current quarter and 11% for the next. The company’s growth estimates for the current quarter and the next is 21.5% and 11.8%, respectively.

Roper Industries’s Revenue

Year-on-year quarterly revenue growth grew by 21.7%, now sitting on 5.99B for the twelve trailing months.

Volatility

Roper Industries’s last week, last month’s, and last quarter’s current intraday variation average was 0.60%, 0.11%, and 1.01%, respectively.

Roper Industries’s highest amplitude of average volatility was 2.18% (last week), 1.03% (last month), and 1.01% (last quarter), respectively.

Roper Industries’s Stock Yearly Top and Bottom Value

Roper Industries’s stock is valued at $475.52 at 07:34 EST, under its 52-week high of $505.00 and way higher than its 52-week low of $365.23.

Roper Industries’s Moving Average

Roper Industries’s value is above its 50-day moving average of $469.05 and above its 200-day moving average of $467.40.

More news about Roper Industries.

Most Active Premarket Losers Today

1. U.S. Gold Corp (USAU) – Premarket: -7.44%

NASDAQ Composite ended the session with U.S. Gold Corp sliding 1.1% to $8.06 on Monday while NASDAQ Composite dropped 0.07% to $15,169.68.

Volume

Today’s last reported volume for U.S. Gold Corp is 66915, 98.03% above its average volume of 33790.

U.S. Gold Corp’s last close was $8.06, 53.68% below its 52-week high of $17.40.

Volatility

U.S. Gold Corp’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.98%, a negative 2.61%, and a positive 2.61%, respectively.

U.S. Gold Corp’s highest amplitude of average volatility was 11.33% (last week), 3.77% (last month), and 2.61% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

U.S. Gold Corp’s stock is considered to be overbought (>=80).

U.S. Gold Corp’s Stock Yearly Top and Bottom Value

U.S. Gold Corp’s stock is valued at $8.06 at 07:34 EST, below its 52-week low of $8.50.

U.S. Gold Corp’s Moving Average

U.S. Gold Corp’s value is way under its 50-day moving average of $10.13 and way below its 200-day moving average of $10.50.

More news about U.S. Gold Corp.

2. West Pharmaceutical (WST) – Premarket: -5.62%

NYSE Composite ended the session with West Pharmaceutical rising 1.12% to $449.81 on Monday, after five successive sessions in a row of gains. NYSE Composite slid 1.07% to $16,668.64, following the last session’s downward trend on what was an all-around bearish trend trading session today.

Volume

Today’s last reported volume for West Pharmaceutical is 616225, 61.62% above its average volume of 381268.

West Pharmaceutical’s last close was $449.81, 5.37% below its 52-week high of $475.35.

West Pharmaceutical’s Sales

West Pharmaceutical’s sales growth is 25.4% for the ongoing quarter and 21.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 56.5% and 41.8%, respectively.

West Pharmaceutical’s Revenue

Year-on-year quarterly revenue growth grew by 37.3%, now sitting on 2.52B for the twelve trailing months.

Volatility

West Pharmaceutical’s last week, last month’s, and last quarter’s current intraday variation average was 1.36%, 0.38%, and 1.44%, respectively.

West Pharmaceutical’s highest amplitude of average volatility was 1.74% (last week), 1.42% (last month), and 1.44% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

West Pharmaceutical’s stock is considered to be oversold (<=20).

West Pharmaceutical’s Stock Yearly Top and Bottom Value

West Pharmaceutical’s stock is valued at $449.81 at 07:34 EST, under its 52-week high of $475.35 and way above its 52-week low of $253.85.

West Pharmaceutical’s Moving Average

West Pharmaceutical’s worth is above its 50-day moving average of $424.37 and way above its 200-day moving average of $379.25.

More news about West Pharmaceutical.

3. Marathon Oil (MRO) – Premarket: -5.48%

NYSE Composite ended the session with Marathon Oil falling 1.37% to $15.15 on Monday while NYSE Composite slid 1.07% to $16,668.64.

Volume

Today’s last reported volume for Marathon Oil is 25042400, 38.28% above its average volume of 18109200.

Marathon Oil’s last close was $15.15, 13.87% below its 52-week high of $17.59.

Marathon Oil’s Sales

Marathon Oil’s sales growth is 70.9% for the current quarter and 55.6% for the next. The company’s growth estimates for the ongoing quarter and the next is 207.1% and 358.3%, respectively.

Marathon Oil’s Revenue

Year-on-year quarterly revenue growth grew by 153.8%, now sitting on 4.03B for the twelve trailing months.

Volatility

Marathon Oil’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.39%, a negative 1.93%, and a positive 2.78%, respectively.

Marathon Oil’s highest amplitude of average volatility was 5.39% (last week), 3.23% (last month), and 2.78% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Marathon Oil’s stock is considered to be overbought (>=80).

Marathon Oil’s Stock Yearly Top and Bottom Value

Marathon Oil’s stock is valued at $15.15 at 07:34 EST, way below its 52-week high of $17.59 and way above its 52-week low of $4.77.

Marathon Oil’s Moving Average

Marathon Oil’s worth is below its 50-day moving average of $15.65 and way higher than its 200-day moving average of $13.07.

More news about Marathon Oil.

4. Plug Power (PLUG) – Premarket: -5.38%

NASDAQ Composite ended the session with Plug Power rising 0.34% to $29.75 on Monday, following the last session’s upward trend. NASDAQ Composite fell 0.07% to $15,169.68, after five successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Plug Power is 21750900, 7.65% below its average volume of 23553200.

Plug Power’s last close was $29.75, 60.59% under its 52-week high of $75.49.

Plug Power’s Sales

Plug Power’s sales growth is 12.2% for the current quarter and 62% for the next. The company’s growth estimates for the present quarter and the next is 18.2% and 93.8%, respectively.

Plug Power’s Revenue

Year-on-year quarterly revenue growth grew by 83.2%, now sitting on -5.54M for the twelve trailing months.

Volatility

Plug Power’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.59%, a negative 2.23%, and a positive 3.74%, respectively.

Plug Power’s highest amplitude of average volatility was 6.76% (last week), 3.51% (last month), and 3.74% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Plug Power’s stock is considered to be overbought (>=80).

Plug Power’s Stock Yearly Top and Bottom Value

Plug Power’s stock is valued at $29.75 at 07:34 EST, way under its 52-week high of $75.49 and way above its 52-week low of $18.47.

Plug Power’s Moving Average

Plug Power’s value is way below its 50-day moving average of $36.41 and below its 200-day moving average of $31.07.

More news about Plug Power.

5. Banco Bradesco (BBDO) – Premarket: -5.35%

NYSE Composite ended the session with Banco Bradesco rising 5.65% to $3.18 on Monday while NYSE Composite dropped 1.07% to $16,668.64.

Volume

Today’s last reported volume for Banco Bradesco is 25744, 52.38% below its average volume of 54066.

Banco Bradesco’s last close was $3.18, 35.1% under its 52-week high of $4.90.

Banco Bradesco’s Revenue

Year-on-year quarterly revenue growth grew by 61.3%, now sitting on 91.33B for the twelve trailing months.

Volatility

Banco Bradesco’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.16%, a negative 0.32%, and a positive 2.12%, respectively.

Banco Bradesco’s highest amplitude of average volatility was 2.10% (last week), 1.36% (last month), and 2.12% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Banco Bradesco’s stock is considered to be oversold (<=20).

Banco Bradesco’s Stock Yearly Top and Bottom Value

Banco Bradesco’s stock is valued at $3.18 at 07:34 EST, way under its 52-week high of $4.90 and above its 52-week low of $3.01.

Banco Bradesco’s Moving Average

Banco Bradesco’s worth is under its 50-day moving average of $3.28 and way under its 200-day moving average of $3.88.

More news about Banco Bradesco.

6. Marathon (MARA) – Premarket: -5.04%

NASDAQ Composite ended the session with Marathon falling 4.66% to $33.85 on Monday while NASDAQ Composite fell 0.07% to $15,169.68.

Volume

Today’s last reported volume for Marathon is 10955900, 14.34% below its average volume of 12790900.

Marathon’s last close was $33.85, 59.44% below its 52-week high of $83.45.

Marathon’s Revenue

Year-on-year quarterly revenue growth grew by 6091.1%, now sitting on 92.83M for the twelve trailing months.

Volatility

Marathon’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.88%, a negative 2.82%, and a positive 6.35%, respectively.

Marathon’s highest amplitude of average volatility was 7.88% (last week), 5.41% (last month), and 6.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Marathon’s stock is considered to be overbought (>=80).

Marathon’s Stock Yearly Top and Bottom Value

Marathon’s stock is valued at $33.85 at 07:34 EST, way below its 52-week high of $83.45 and way above its 52-week low of $5.14.

Marathon’s Moving Average

Marathon’s worth is way below its 50-day moving average of $51.69 and way under its 200-day moving average of $37.76.

Previous days news about Marathon

  • Pomerantz law firm announces the filing of a class action against marathon digital holdings, inc. f/k/a marathon patent group, inc. and certain officers – MARA. According to Benzinga on Friday, 17 December, "In October 2020, Marathon announced the formation of a new joint venture with Beowulf Energy LLC ("Beowulf") purportedly focused on delivering low-cost power to Marathon’s Bitcoin mining operations (the "Beowulf Joint Venture"). ", "NEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Marathon Digital Holdings, Inc. f/k/a Marathon Patent Group, Inc. ("Marathon" or the "Company") (NASDAQ:MARA) and certain of its officers. "
  • (mara) deadline: did you suffer a substantial loss? contact johnson fistel about leading marathon digital class action lawsuit. According to Benzinga on Saturday, 18 December, "A lead plaintiff will act on behalf of all other class members in directing the Marathon Digital class-action lawsuit. ", "SAN DIEGO, Dec. 18, 2021 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Marathon Digital Holdings, Inc. f/k/a Marathon Patent Group, Inc. (NASDAQ:MARA) ("Marathon Digital" or the "Company"). "
  • Hagens berman, national trial attorneys, encourages marathon digital holdings (mara) investors to contact firm's attorneys, securities fraud class action filed. According to Benzinga on Saturday, 18 December, "The truth emerged on Nov. 15, 2021, when Marathon announced that it and certain of its executives received a subpoena from the SEC seeking documents and communications concerning the Hardin Facility. ", "In connection with that joint venture, Marathon entered into a series of agreements with multiple parties to design and build the Hardin Facility, issuing 6 million shares to the parties of those agreements."

More news about Marathon.

7. LendingTree (TREE) – Premarket: -4.8%

NASDAQ Composite ended the session with LendingTree jumping 4.55% to $120.80 on Monday, after four consecutive sessions in a row of gains. NASDAQ Composite fell 0.07% to $15,169.68, after five consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for LendingTree is 509062, 49.43% above its average volume of 340658.

LendingTree’s last close was $120.80, 67.58% below its 52-week high of $372.64.

LendingTree’s Sales

LendingTree’s sales growth is 32.8% for the present quarter and 23.9% for the next. The company’s growth estimates for the present quarter and the next is 319.2% and 407.7%, respectively.

LendingTree’s Revenue

Year-on-year quarterly revenue growth grew by 35.1%, now sitting on 1.06B for the twelve trailing months.

Volatility

LendingTree’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.97%, a negative 0.38%, and a positive 2.79%, respectively.

LendingTree’s highest amplitude of average volatility was 3.97% (last week), 2.43% (last month), and 2.79% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

LendingTree’s stock is considered to be oversold (<=20).

LendingTree’s Stock Yearly Top and Bottom Value

LendingTree’s stock is valued at $120.80 at 07:34 EST, way under its 52-week high of $372.64 and way higher than its 52-week low of $105.00.

LendingTree’s Moving Average

LendingTree’s value is way under its 50-day moving average of $136.66 and way below its 200-day moving average of $182.88.

More news about LendingTree.

8. Occidental Petroleum (OXY) – Premarket: -4.74%

NYSE Composite ended the session with Occidental Petroleum falling 1.2% to $28.04 on Monday, after five sequential sessions in a row of losses. NYSE Composite fell 1.07% to $16,668.64, following the last session’s downward trend on what was an all-around negative trend trading session today.

Volume

Today’s last reported volume for Occidental Petroleum is 23183900, 38.18% above its average volume of 16777900.

Occidental Petroleum’s last close was $28.04, 21.57% under its 52-week high of $35.75.

Occidental Petroleum’s Sales

Occidental Petroleum’s sales growth is 96.8% for the current quarter and 83.7% for the next. The company’s growth estimates for the present quarter and the next is 170.2% and 153.8%, respectively.

Occidental Petroleum’s Revenue

Year-on-year quarterly revenue growth grew by 103.5%, now sitting on 19.52B for the twelve trailing months.

Volatility

Occidental Petroleum’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.81%, a negative 2.09%, and a positive 3.03%, respectively.

Occidental Petroleum’s highest amplitude of average volatility was 5.81% (last week), 3.40% (last month), and 3.03% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Occidental Petroleum’s stock is considered to be overbought (>=80).

Occidental Petroleum’s Stock Yearly Top and Bottom Value

Occidental Petroleum’s stock is valued at $28.04 at 07:34 EST, way below its 52-week high of $35.75 and way higher than its 52-week low of $11.19.

Occidental Petroleum’s Moving Average

Occidental Petroleum’s worth is way under its 50-day moving average of $32.39 and below its 200-day moving average of $28.32.

More news about Occidental Petroleum.

9. QuantumScape (QS) – Premarket: -4.71%

NYSE Composite ended the session with QuantumScape rising 3.21% to $23.78 on Monday while NYSE Composite slid 1.07% to $16,668.64.

Volume

Today’s last reported volume for QuantumScape is 12746400, 0.55% above its average volume of 12675700.

QuantumScape’s last close was $23.78, 82.08% below its 52-week high of $132.73.

Volatility

QuantumScape’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.98%, a negative 1.71%, and a positive 3.64%, respectively.

QuantumScape’s highest amplitude of average volatility was 2.39% (last week), 2.60% (last month), and 3.64% (last quarter), respectively.

QuantumScape’s Stock Yearly Top and Bottom Value

QuantumScape’s stock is valued at $23.78 at 07:34 EST, way under its 52-week high of $132.73 and way higher than its 52-week low of $13.71.

QuantumScape’s Moving Average

QuantumScape’s worth is way below its 50-day moving average of $26.47 and below its 200-day moving average of $25.87.

More news about QuantumScape.

10. Uber (UBER) – Premarket: -4.66%

NYSE Composite ended the session with Uber jumping 5.25% to $39.68 on Monday while NYSE Composite slid 1.07% to $16,668.64.

Volume

Today’s last reported volume for Uber is 50313700, 75.43% above its average volume of 28679500.

Uber’s last close was $39.68, 38.05% under its 52-week high of $64.05.

Uber’s Sales

Uber’s sales growth is 42.2% for the ongoing quarter and 54.2% for the next. The company’s growth estimates for the current quarter and the next is 40.3% and 50%, respectively.

Uber’s Revenue

Year-on-year quarterly revenue growth grew by 105.4%, now sitting on 12.81B for the twelve trailing months.

Volatility

Uber’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.29%, a negative 0.05%, and a positive 2.82%, respectively.

Uber’s highest amplitude of average volatility was 2.44% (last week), 2.75% (last month), and 2.82% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Uber’s stock is considered to be oversold (<=20).

Uber’s Stock Yearly Top and Bottom Value

Uber’s stock is valued at $39.68 at 07:34 EST, way below its 52-week high of $64.05 and higher than its 52-week low of $38.08.

Uber’s Moving Average

Uber’s value is way under its 50-day moving average of $45.12 and way below its 200-day moving average of $48.73.

More news about Uber.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here